Perseon's (PRSN) MicroThermX Cleared by FDA for Laparoscopic Ablation Procedures

April 8, 2015 9:17 AM EDT

Perseon Corporation (Nasdaq: PRSN) announced that the company received clearance from the U.S. Food and Drug Administration (FDA) to market the MicroThermX Microwave Ablation System (MicroThermX) for the specific indication of laparoscopic ablation procedures using image guidance.

"This new indication increases the type of cases that our technology will be used for and the opportunity to expand the use of MicroThermX in surgical oncology," said Clint Carnell, CEO of Perseon. "This moves us closer to achieving our clinical initiatives to benefit patients, physicians, and the healthcare system worldwide."

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

Corporate News, FDA, Hot Corp. News, Hot FDA News, Management Comments